Table 2.
Treatment guidelines for patients with BCLC-B HCC in Japan (TAE Research Group of Japan) [17]
Subsubstage | Stage-B1 | Stage-B2 | Stage-B3 |
---|---|---|---|
Liver Function and | CP score 5–6 | Other than | CP-9? |
Tumor status | 4–7 cm IN | B1 and B3 | |
Treatment option | RFA | TACE | HAIC |
LT | |||
Alternative | TACE (+RFA) | HAIC SOR | BSC |
TAE=transarterial embolization; CP=Child-Pugh.